- Home
- FLYX vs CNTB Comparison
FLYX vs CNTB Comparison
Compare FLYX & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLYX
- CNTB
- Stock Information
- Founded
- FLYX 2015
- CNTB 2012
- Country
- FLYX United States
- CNTB United States
- Employees
- FLYX N/A
- CNTB N/A
- Industry
- FLYX Blank Checks
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- FLYX Finance
- CNTB Health Care
- Exchange
- FLYX Nasdaq
- CNTB Nasdaq
- Market Cap
- FLYX 54.1M
- CNTB 44.2M
- IPO Year
- FLYX N/A
- CNTB 2021
- Fundamental
- Price
- FLYX $2.63
- CNTB $1.03
- Analyst Decision
- FLYX
- CNTB Strong Buy
- Analyst Count
- FLYX 0
- CNTB 2
- Target Price
- FLYX N/A
- CNTB $7.50
- AVG Volume (30 Days)
- FLYX 13.8K
- CNTB 91.6K
- Earning Date
- FLYX 08-13-2025
- CNTB 05-15-2025
- Dividend Yield
- FLYX N/A
- CNTB N/A
- EPS Growth
- FLYX N/A
- CNTB N/A
- EPS
- FLYX N/A
- CNTB N/A
- Revenue
- FLYX $335,427,000.00
- CNTB $26,033,000.00
- Revenue This Year
- FLYX $28.47
- CNTB N/A
- Revenue Next Year
- FLYX $22.44
- CNTB N/A
- P/E Ratio
- FLYX N/A
- CNTB N/A
- Revenue Growth
- FLYX 5.38
- CNTB N/A
- 52 Week Low
- FLYX $1.79
- CNTB $0.51
- 52 Week High
- FLYX $5.19
- CNTB $1.73
- Technical
- Relative Strength Index (RSI)
- FLYX 42.81
- CNTB 67.44
- Support Level
- FLYX $2.77
- CNTB $0.75
- Resistance Level
- FLYX $2.80
- CNTB $1.12
- Average True Range (ATR)
- FLYX 0.23
- CNTB 0.07
- MACD
- FLYX -0.04
- CNTB 0.03
- Stochastic Oscillator
- FLYX 15.06
- CNTB 76.92
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.